![FDA Approves Hepatitis C Treatment Co-Invented by Texas ChE Ph.D. Student](https://che.utexas.edu/wp-content/uploads/18866407906_7d74bd75e4_z.jpg)
Today the U.S. Food and Drug Administration approved the drug product Zepatier for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients. Texas ChE Ph.D. student Angela Wagner of Professor Nicholas Peppas’ research group was one of the team of eight researchers to co-invent and patent Zepatier.
Hepatitis … Read the rest »